Evidence 1
Activity
Activity
30% Killing
Toxicity
10 µM
Cytotoxic
30% Killing | 10 | µM | target cell: Human embryonic kidney HEK293 cells
Target
Human embryonic kidney HEK293 cells
Source & Reference
NA
DBAASP
Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy. | Oncotarget | 2016